|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net income (loss) | |||||
| Net income from discontinued operations, net of tax | |||||
| Net loss from continuing operations | |||||
| Adjustments to reconcile net income (loss) from continuing operations to cash used in operating activities: | |||||
| Stock-based compensation expense | |||||
| Depreciation and amortization | |||||
| (Reduction in) provision for bad debt | |||||
| Loss (gain) on commodity derivative contracts | |||||
| Provision for environment clean up | |||||
| Gain on forgiveness of debt | |||||
| Net cash settlement on commodity derivatives | |||||
| Loss on sale of assets | |||||
| Loss on assets impairment | |||||
| Amortization of debt discount and deferred costs | |||||
| Deferred income tax benefit | |||||
| Loss (gain) on change in value of derivative warrant liability | |||||
| Reduction in contingent consideration | |||||
| Changes in operating assets and liabilities, net of acquisitions: | |||||
| Accounts receivable | |||||
| Inventory | |||||
| Prepaid expenses | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Other assets | |||||
| Net cash (used in) provided by operating activities from continuing operations | |||||
| Cash flows from investing activities | |||||
| Deposit for refinery purchase and related costs | |||||
| Internally developed or purchased software | |||||
| Proceeds from sale of discontinued operation | |||||
| Redemption of noncontrolling entity | |||||
| Proceeds from the sale of assets | |||||
| Acquisition of business, net of cash | |||||
| Purchase of fixed assets | |||||
| Net cash used in investing activities from continuing operations | |||||
| Cash flows from financing activities | |||||
| Line of credit payments, net | |||||
| Proceeds received from exercise of options and warrants | |||||
| Proceeds received from issuance of common stock options and warrants | |||||
| Net borrowings on inventory financing agreements | |||||
| Contribution received from noncontrolling interest | |||||
| Distribution to non-controlling interest | |||||
| Redemption of redeemable noncontrolling interest | |||||
| Payments on finance leases | |||||
| Payment of debt issuance costs | |||||
| Proceeds from issuance of notes payable | |||||
| Payments made on notes payable | |||||
| Net cash provided by financing activities from continuing operations | |||||
| Discontinued operations: | |||||
| Net cash (used in) provided by operating activities | |||||
| Net cash used in investing activities | |||||
| Net cash used in financing activities | |||||
| Net cash provided by (used in) discontinued operations | |||||
| Net change in cash and cash equivalents and restricted cash | |||||
| Cash and cash equivalents and restricted cash at beginning of the year | |||||
| Cash and cash equivalents and restricted cash at end of year | |||||
| SUPPLEMENTAL INFORMATION | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| NON-CASH INVESTING AND FINANCING TRANSACTIONS | |||||
| Conversion of Series B and B1 Preferred Stock into common stock | |||||
| Dividends on Series B and B-1 Preferred Stock | |||||
| Initial carrying amount of non-controlling interest | |||||
| Accretion of discount on Series B and B-1 Preferred Stock | |||||
| Accretion of redeemable noncontrolling interest to redemption value | |||||
| Equipment acquired under finance leases | |||||
| Equipment acquired under operating leases | |||||
| Reclass derivative liabilities | |||||
| Conversion of Convertible Senior note, including inducement common stock | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
Loading...